Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Return on Invested Capital (2022 - 2025)

Historic Return on Invested Capital for Puma Biotechnology (PBYI) over the last 5 years, with Q3 2025 value amounting to 0.23%.

  • Puma Biotechnology's Return on Invested Capital fell 600.0% to 0.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 0.27% for FY2024, which is 3000.0% down from last year.
  • Puma Biotechnology's Return on Invested Capital amounted to 0.23% in Q3 2025, which was down 600.0% from 0.32% recorded in Q2 2025.
  • In the past 5 years, Puma Biotechnology's Return on Invested Capital registered a high of 1.09% during Q1 2023, and its lowest value of 11.5% during Q1 2022.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.26% (2025), whereas its average is 0.35%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first tumbled by -8900bps in 2022, then soared by 125900bps in 2023.
  • Over the past 5 years, Puma Biotechnology's Return on Invested Capital (Quarter) stood at 0.9% in 2021, then plummeted by -99bps to 0.0% in 2022, then surged by 8703bps to 0.42% in 2023, then crashed by -44bps to 0.23% in 2024, then decreased by -4bps to 0.23% in 2025.
  • Its last three reported values are 0.23% in Q3 2025, 0.32% for Q2 2025, and 0.26% during Q1 2025.